白宮要打壓最掙錢的10個藥價格，藥股慘了

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

所有跟帖： 

• 狼來了幾次了，讓公司先倒閉吧 -hz82000- ♀ (0 bytes) () 08/29/2023 postreply 07:30:52

• 可以讓白宮把製藥公司都收歸國有，然後提供免費藥物。 -年輪- ♂ (0 bytes) () 08/29/2023 postreply 07:32:42

• capitalism變身socialism -flyingcandle- ♂ (0 bytes) () 08/29/2023 postreply 07:34:01

• 美國從中國學了很多 -z10- ♀ (0 bytes) () 08/29/2023 postreply 07:40:17